Statin prescription adhered to guidelines for patients hospitalized due to acute ischemic stroke or transient ischemic attack

Journal of Clinical Neurology (Korea)

Volumn 9, Issue 4, 2013, Pages 214-222

  Hong, Keun Sik ^a   Sun Oh, Mi ^b   Choi, Hye Yeon ^c   Cho, A Hyun ^d   Kwon, Hyung Min ^e   Yu, Kyung Ho ^b   Bae, Hee Joon ^f   Lee, Juneyoung ^g   Lee, Byung Chul ^b  

^a Inje University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Seoul National University Bundang Hospital   (South Korea)

^g Korea University College of Medicine   (South Korea)

Author keywords

Adherence; Guideline; Ischemic stroke; Secondary stroke prevention; Statin; Transient ischemic attack

Indexed keywords

EID: 84885048734     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2013.9.4.214     Document Type: Article

References (15)

1. Hong KS, Bang OY, Kang DW, Yu KH, Bae HJ, Lee JS, et al. Stroke statistics in Korea: Part I. Epidemiology and risk factors: a report from the Korean Stroke Society and Clinical Research Center for Stroke. J Stroke 2013;15:2-20.
2. Jung KH, Lee SH, Kim BJ, Yu KH, Hong KS, Lee BC, et al. Secular trends in ischemic stroke characteristics in a rapidly developed coun try: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes 2012;5:327-334.
3. Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997;48:891-895.
4. Hong KS, Yegiaian S, Lee M, Lee J, Saver JL. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation 2011;123:2111-2119.
5. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
6. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009;8:453-463.
7. Hwang JY, Jung CH, Lee WJ, Park CY, Kim SR, Yoon KH, et al. Low density lipoprotein cholesterol target goal attainment rate and physician perceptions about target goal achievement in Korean patients with diabetes. Diabetes Metab J 2011;35:628-636.
8. Ovbiagele B, Schwamm LH, Smith EE, Hernandez AF, Olson DM, Pan W, et al. Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. Stroke 2010;41:1508-1513.
9. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.
10. Heidrich J, Behrens T, Raspe F, Keil U. Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005;12:521-529.
11. Virani SS, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, et al. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med 2011;124:876-880.e2.
12. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000;160:2281-2286.
13. Sisson SD, Rice TN, Hughes MT. Physician knowledge of national cholesterol guidelines before and after an interactive curriculum. Am J Cardiol 2007;99:1234-1235.
14. Touzé E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005;36:2748-2755.
15. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology 2006;66:641-646.